Aerie Pharmaceuticals


Aerie Pharmaceuticals  Stock Quote
$21.50 -$1.06 -4.7%
BATS BZX Real Time Price as of January 24, 2020, 4:30 p.m. EST View Interactive AERI Charts

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company engaged in the discovery development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

News & Analysis: Aerie Pharmaceuticals


Market Moves


Is Aerie Pharmaceuticals a Buy?

The small-cap company's shares have fallen 64% in the last year, but a promising drug portfolio might signal an opportunity for investors with a long-term mindset.

Interactive Chart